JAN vs. OPTI, IDP, BON, BSFA, RGO, IRON, AAAP, GILD, TECH, and BRNS
Should you be buying Jangada Mines stock or one of its competitors? The main competitors of Jangada Mines include OptiBiotix Health (OPTI), InnovaDerma (IDP), Bonmarche (BON), BSF Enterprise (BSFA), RiverFort Global Opportunities (RGO), Ironveld (IRON), Anglo African Agriculture (AAAP), Guild Esports (GILD), TechFinancials (TECH), and (BRNS.L) (BRNS). These companies are all part of the "pharmaceutical products" industry.
Jangada Mines vs. Its Competitors
Jangada Mines (LON:JAN) and OptiBiotix Health (LON:OPTI) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.
Jangada Mines has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.71, meaning that its stock price is 71% more volatile than the S&P 500.
In the previous week, OptiBiotix Health had 1 more articles in the media than Jangada Mines. MarketBeat recorded 1 mentions for OptiBiotix Health and 0 mentions for Jangada Mines. OptiBiotix Health's average media sentiment score of 0.03 beat Jangada Mines' score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the news media.
0.0% of Jangada Mines shares are held by institutional investors. Comparatively, 4.9% of OptiBiotix Health shares are held by institutional investors. 49.2% of Jangada Mines shares are held by company insiders. Comparatively, 12.0% of OptiBiotix Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Jangada Mines has a net margin of 0.00% compared to OptiBiotix Health's net margin of -524.43%. Jangada Mines' return on equity of -0.02% beat OptiBiotix Health's return on equity.
Jangada Mines has higher earnings, but lower revenue than OptiBiotix Health. Jangada Mines is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.
Summary
OptiBiotix Health beats Jangada Mines on 7 of the 12 factors compared between the two stocks.
Get Jangada Mines News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAN and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jangada Mines Competitors List
Related Companies and Tools
This page (LON:JAN) was last updated on 7/2/2025 by MarketBeat.com Staff
